{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:24:09Z","timestamp":1780568649511,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cca.2021.01.015","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T21:55:11Z","timestamp":1611611711000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients"],"prefix":"10.1016","volume":"516","author":[{"given":"Yung-Chuan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-9901","authenticated-orcid":false,"given":"Cheng-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2517-2012","authenticated-orcid":false,"given":"I-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6206-016X","authenticated-orcid":false,"given":"Wei-Chin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thung-Lip","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-8310","authenticated-orcid":false,"given":"Chin-Feng","family":"Hsuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Hung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Ting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-5302","authenticated-orcid":false,"given":"Fu-Mei","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Jiunn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7387-787X","authenticated-orcid":false,"given":"Chao-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2021.01.015_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018438","article-title":"Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations","volume":"6","author":"Mutsaers","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2021.01.015_b0010","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/pr200093w","article-title":"Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1)","volume":"10","author":"Wikoff","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2021.01.015_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cca.2021.01.015_b0020","doi-asserted-by":"crossref","first-page":"26715","DOI":"10.1038\/srep26715","article-title":"Bioengineered kidney tubules efficiently excrete uremic toxins","volume":"6","author":"Jansen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2021.01.015_b0025","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.tiv.2015.07.020","article-title":"Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology","volume":"29","author":"Mutsaers","year":"2015","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.cca.2021.01.015_b0030","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1159\/000313491","article-title":"Spherical carbon adsorbent (AST-120) protects deterioration of renal function in chronic kidney disease rats through inhibition of reactive oxygen species production from mitochondria and reduction of serum lipid peroxidation","volume":"115","author":"Owada","year":"2010","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0035","first-page":"142","article-title":"Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration","volume":"1832","author":"Mutsaers","year":"2013","journal-title":"BBA"},{"key":"10.1016\/j.cca.2021.01.015_b0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.atherosclerosis.2010.03.036","article-title":"Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure","volume":"211","author":"Wang","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2021.01.015_b0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11255-012-0258-1","article-title":"An update on uremic toxins","volume":"45","author":"Neirynck","year":"2013","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial","volume":"54","author":"Akizawa","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2021.01.015_b0055","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"European Uremic Toxin Work Group (EUTox). Review on uremic toxins: classification, concentration and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2021.01.015_b0060","article-title":"Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients","volume":"10","author":"Tang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2021.01.015_b0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2016.03.012","article-title":"Associations among chronic kidney disease, high total p-cresylsulfate and left ventricular systolic dysfunction","volume":"457","author":"Lu","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2021.01.015_b0070","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1681\/ASN.2018060609","article-title":"Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance","volume":"30","author":"Opdebeeck","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0075","doi-asserted-by":"crossref","first-page":"S278","DOI":"10.1046\/j.1523-1755.2001.59780278.x","article-title":"Hippurate participates in the correction of metabolic acidosis","volume":"78","author":"Dz\u00farik","year":"2001","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.cca.2021.01.015_b0080","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1248\/bpb.18.1755","article-title":"Characterization of binding site of uremic toxins on human serum albumin","volume":"18","author":"Sakai","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cca.2021.01.015_b0085","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI108031","article-title":"Uricosuric agents in uremic sera. Identification of indoxyl sulfate and hippuric acid","volume":"55","author":"Boumendil-Podevin","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2021.01.015_b0090","first-page":"79","article-title":"Hippurate participation in the inhibition of glucose utilization in renal failure","volume":"10","author":"Spustova","year":"1987","journal-title":"Czech Med."},{"key":"10.1016\/j.cca.2021.01.015_b0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0378-4347(00)82773-5","article-title":"Inhibition of glucose utilization in uremia by hippurate: liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification","volume":"490","author":"Spustova","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.cca.2021.01.015_b0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-8981(89)90134-4","article-title":"Biochemical and neurophysiological parameters in hemodialyzed patients with chronic renal failure","volume":"185","author":"Schoots","year":"1989","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2021.01.015_b0105","first-page":"723","article-title":"Secretory activity and aryl acid content of serum, urine and cerebrospinal fluid in normal and uremic man","volume":"85","author":"Porter","year":"1975","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cca.2021.01.015_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1471-4159.2002.01108.x","article-title":"Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain","volume":"83","author":"Ohtsuki","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2021.01.015_b0115","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1159\/000074327","article-title":"Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure","volume":"95","author":"Satoh","year":"2003","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cca.2018.05.022","article-title":"Association between hippuric acid and left ventricular hypertrophy in maintenance hemodialysis patients","volume":"484","author":"Yu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2021.01.015_b0125","first-page":"42","article-title":"Accumulated experience in the analysis of quality indicators in a haemodialysis unit","volume":"29","author":"Del Pozo","year":"2009","journal-title":"Nefrologia"},{"issue":"65","key":"10.1016\/j.cca.2021.01.015_b0130","first-page":"281","article-title":"Uremic neuropathy: an overview of the current literature","volume":"2019","author":"Camargo","year":"1992","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.cca.2021.01.015_b0135","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/ndt\/gfn098","article-title":"The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients","volume":"23","author":"Cohen","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2021.01.015_b0140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00004872-200205000-00018","article-title":"White blood cell count as a risk factor for hypertension; a study of Japanese male office workers","volume":"20","author":"Nakanishi","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cca.2021.01.015_b0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/CH-2009-1173","article-title":"Pathophysiology of polymorphonuclear leukocyte in arterial hypertension","volume":"41","author":"Hopps","year":"2009","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.cca.2021.01.015_b0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005022","article-title":"Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease","volume":"6","author":"Hung","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2021.01.015_b0155","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ckj\/sfy056","article-title":"Using the newer Kidney Disease: Improving Global Outcomes criteria, beta-2-microglobulin levels associate with severity of acute kidney injury","volume":"11","author":"Barton","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.cca.2021.01.015_b0165","first-page":"492","article-title":"The clinical significance of beta2- microglobulin in end-stage renal disease","volume":"14","author":"Al-Taee","year":"2003","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"10.1016\/j.cca.2021.01.015_b0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/bdd.1834","article-title":"Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate","volume":"34","author":"Viaene","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.cca.2021.01.015_b0175","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00216-012-5929-3","article-title":"Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production","volume":"403","author":"Itoh","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2021.01.015_b0180","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.colsurfb.2014.09.044","article-title":"Interaction of 5-fluoro-5'-deoxyuridine with human serum albumin under physiological and non-physiological condition: a biophysical investigation","volume":"123","author":"Ishtikhar","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.cca.2021.01.015_b0185","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1021\/mp500116c","article-title":"Insight into the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches","volume":"11","author":"Rehman","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cca.2021.01.015_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071422","article-title":"A comprehensive insight into binding of hippuric acid to human serum albumin: a study to uncover its impaired elimination through hemodialysis","volume":"8","author":"Zaidi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2021.01.015_b0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1525-1594.2012.01570.x","article-title":"Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique","volume":"37","author":"Brettschneider","year":"2013","journal-title":"Artif. Organs"},{"key":"10.1016\/j.cca.2021.01.015_b0200","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.ajkd.2015.08.029","article-title":"Future avenues to decrease uremic toxin concentration","volume":"67","author":"Vanholder","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2021.01.015_b0205","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.3390\/toxins7103933","article-title":"Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis","volume":"7","author":"Deltombe","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cca.2021.01.015_b0210","first-page":"583","article-title":"Kinetics of protein-bound solutes during hemodialysis","volume":"35","author":"Eloot","year":"2012","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.cca.2021.01.015_b0215","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1523-1755.2000.00398.x","article-title":"Mass spectrometric monitoring of albumin in uremia","volume":"58","author":"Thornalley","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2021.01.015_b0220","doi-asserted-by":"crossref","first-page":"23389","DOI":"10.1038\/srep23389","article-title":"Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study","volume":"6","author":"Tao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2021.01.015_b0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/toxins9010025","article-title":"Impact of indoxyl sulfate on progenitor cell-related neovascularization of peripheral arterial disease and post-angioplasty thrombosis of dialysis vascular access","volume":"9","author":"Wu","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cca.2021.01.015_b0230","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0378-4347(00)82773-5","article-title":"Inhibition of glucose utilization in uremia by hippurate: liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification","volume":"490","author":"Spustov\u00e1","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.cca.2021.01.015_b0235","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/ndt\/gft466","article-title":"Differential scaling of glomerular filtration rate and ingested metabolic burden: implications for gender differences in chronic kidney disease outcomes","volume":"29","author":"Ellam","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2021.01.015_b0240","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40620-015-0195-z","article-title":"Association of advanced age with concentrations of uraemic toxins in CKD","volume":"29","author":"Rroji","year":"2016","journal-title":"J. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0245","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ki.2012.301","article-title":"Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients","volume":"82","author":"Liabeuf","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2021.01.015_b0250","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2021.01.015_b0255","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0260","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2215\/CJN.07971109","article-title":"p-Cresol and cardiovascular risk in mild-to-moderate kidney disease","volume":"5","author":"Meijers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0265","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2005.05.009","article-title":"Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?","volume":"46","author":"Kielstein","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2021.01.015_b0270","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2021.01.015_b0275","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000181194","article-title":"Binding of hippurate in normal plasma and in uremic plasma pre-and postdialysis","volume":"20","author":"Farrell","year":"1978","journal-title":"Nephron"},{"key":"10.1016\/j.cca.2021.01.015_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodqual.2019.103859","article-title":"Gender differences in vegetarian identity: How men and women construe meatless dieting","volume":"81","author":"Rosenfeld","year":"2020","journal-title":"Food Qual. Prefer."},{"key":"10.1016\/j.cca.2021.01.015_b0285","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2215\/CJN.02940509","article-title":"p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients","volume":"4","author":"Meijers","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2021.01.015_b0290","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/elps.200600030","article-title":"Capillary electrophoresis for the analysis of small-molecule pharmaceuticals","volume":"27","author":"Altria","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.cca.2021.01.015_b0295","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/antiox9090783","article-title":"Hippuric acid promotes renal fibrosis by disrupting redox homeostasis via facilitation of NRF2-KEAP1-CUL3 interactions in chronic kidney disease","volume":"9","author":"Sun","year":"2020","journal-title":"Antioxidants (Basel)"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121000310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898121000310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:58:47Z","timestamp":1757861927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898121000310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":59,"alternative-id":["S0009898121000310"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2021.01.015","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2021.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}